Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Chronic illness adherence and transition

Paediatrics and child health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Treatment interruption with acute risk

Missed insulin, steroids, anticonvulsants, transplant immunosuppression, anticoagulation or other critical treatment can cause rapid metabolic crisis, adrenal collapse, seizure, rejection, thrombosis or other life-threatening deterioration.

Action: Assess ABCDE and disease-specific observations and tests, restore or modify essential treatment under the relevant emergency protocol, identify intentional or practical interruption privately, involve the specialist team immediately, and address suicide, coercion, neglect or access barriers in parallel.

Synopsis

Support adolescents with chronic illness to understand and manage treatment, identify practical and emotional barriers without blame, preserve safety when adherence falters, develop autonomy alongside carers, and transfer care through a coordinated, developmentally appropriate process with no loss of clinical ownership.

  • Ask the young person privately and non-judgementally how treatment actually fits into each day, what is missed, what happens afterward and what makes adherence easier or harder.
  • Distinguish knowledge, memory, executive function, side effects, formulation, cost, transport, pharmacy supply, stigma, family conflict, mood, eating disorder and deliberate risk because each needs a different response.
  • Use objective data such as refill history, monitoring results and device downloads as a shared problem-solving aid, not as evidence in a confrontation.
  • Explain the immediate and cumulative consequences of interruption in concrete language, prioritising an emergency or sick-day plan for high-risk medicines and devices.
  • Begin transition planning early, revisit it regularly and adjust for development and complexity; transfer is the event within a longer process, not a birthday-based administrative discharge.
  • Teach skills progressively: naming the condition and medicines, ordering supplies, booking appointments, asking questions, understanding consent and confidentiality, and knowing when and how to seek urgent help.
  • Keep parents or carers involved in a role agreed with the young person while testing that safety tasks are genuinely mastered rather than withdrawing support abruptly.
  • Use a named transition coordinator, joint or overlapping communication where possible, a concise health passport and confirmation that the adult service has accepted responsibility.
  • After transfer, verify attendance, prescriptions, monitoring and pending actions; missed first appointments should trigger active contact rather than immediate discharge.

Key red flags

Repeated emergency attendance, unexplained biochemical deterioration, unexpected drug levels or prescription gaps may indicate non-adherence, access failure, distress, cognitive overload or safeguarding harm.

Intentional omission to change weight, cause injury, avoid school, obtain admission or express hopelessness requires direct mental-health and functional assessment rather than punishment.

A parent or partner controlling medicine, appointments, communication or benefits may compromise autonomy and can indicate neglect, coercion or exploitation.

Transfer with no named adult clinician, no accepted referral, incomplete medication supply or uncommunicated pending results creates immediate avoidable clinical risk.

Loss of competence or severe illness during transition requires renewed supported decision-making and safety planning; chronological age does not make independence automatic.

Investigation priorities

01
Collaborative treatment reconstructionFirst step

Establish actual dosing, technique, interruptions and barriers without blame.

Management branches

SafetyRespond to dangerous interruption

Critical treatment has stopped or disease control suggests imminent decompensation.

  1. Assess ABCDE and activate the disease-specific emergency plan, urgent tests and specialist review.
  2. Reconcile what was prescribed, supplied and taken and restore essential treatment safely under the relevant protocol.
  3. Ask privately about suicide, weight control, side effects, coercion, neglect and practical access while avoiding accusatory language.
  4. Discharge only with sufficient supply, a workable emergency plan, named follow-up and action on the identified barrier.
Open full textbook →Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE Transition from children's to adults' services NG43Person-centred planning, named workers, developmentally appropriate support, information transfer and follow-up around service transition.
  • NICE Medicines adherence CG76Shared decision-making and structured exploration of intentional and unintentional barriers to medicine use.
  • GMC 0 to 18 years guidanceCommunication, consent, confidentiality and developing autonomy in medical care for children and young people.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom